Supplementary MaterialsAdditional document 1. (34K) GUID:?77E064EA-ECB4-49C9-8A59-299C5B9E77D3 Additional file 8: Figure S6. RBGO2, RBGO3 and RBGO4 preferentially target endometrial cancer cells and increase drug sensitivity by up to 40-fold. 40425_2019_765_MOESM8_ESM.jpg (46K) GUID:?2CC22CC2-5D0F-4F49-B5BE-23DA938C1AD0 Additional file 9: Figure S7. Blocking experiments confirm the specificity of RBGO1 for RAGE. 40425_2019_765_MOESM9_ESM.jpg (24K) GUID:?C10BBB7D-7E14-4C61-AC4C-3CDF033EC288 Additional file 10: Table S2. Animal full… Continue reading Supplementary MaterialsAdditional document 1. (34K) GUID:?77E064EA-ECB4-49C9-8A59-299C5B9E77D3 Additional file 8: Figure S6.